A Novel Class of Common Docking Domain Inhibitors That Prevent ERK2 Activation and Substrate Phosphorylation-Reference-Cited by-同舟云学术

A Novel Class of Common Docking Domain Inhibitors That Prevent ERK2 Activation and Substrate Phosphorylation

Published:2019-05-06 Issue:6 Volume:14 Page:1183-1194
ISSN:1554-8929
Container-title:ACS Chemical Biology
language:en
Short-container-title:ACS Chem. Biol.

Author:

Sammons Rachel M.^ORCID,Perry Nicole A.,Li Yangmei¹²,Cho Eun Jeong,Piserchio Andrea³,Zamora-Olivares Diana P.,Ghose Ranajeet³,Kaoud Tamer S.⁴^ORCID,Debevec Ginamarie¹,Bartholomeusz Chandra,Gurevich Vsevolod V.,Iverson Tina M.,Giulianotti Marc¹,Houghten Richard A.¹,Dalby Kevin N.^ORCID

Affiliation:

1. Torrey Pines Institute for Molecular Studies, Port St. Lucie, Florida 34987, United States

2. Department of Drug Discovery & Biomedical Sciences, University of South Carolina, Columbia, South Carolina 29208, United States

3. Department of Chemistry and Biochemistry, The City College of New York, New York, New York 10031, United States

4. Department of Medicinal Chemistry, Faculty of Pharmacy, Minia University, 61519 Minia, Egypt

Funder

Vanderbilt University

Welch Foundation

Florida Department of Health

American Heart Association

Cancer Prevention and Research Institute of Texas

National Institutes of Health